Form 4: USANA Health Sciences Director Peggie Pelosi Acquires Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Director Peggie Pelosi acquired 2,697 restricted stock units in USANA Health Sciences, according to a recent SEC filing.

Summary

  • Peggie Pelosi, a director of USANA Health Sciences Inc., acquired 2,697 restricted stock units on May 2, 2024.
  • These restricted stock units represent a contingent right to receive one share of USNA common stock each.
  • The units vest in four equal installments: 25% on August 2, 2024, November 2, 2024, February 2, 2025, and May 2, 2025.
  • The transaction was reported on May 3, 2024, by Joshua Foukas, Attorney-in-Fact.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. It reflects a routine insider transaction, which can be interpreted as a sign of confidence, but it's not a major event.

Positives

  • The acquisition of restricted stock units by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The vesting schedule of the restricted stock units suggests a multi-year commitment by the director to the company's success.

Industry Context

Insider transactions are closely monitored as they can provide insights into management's perspective on the company's valuation and future prospects within the health sciences industry.

Stakeholder Impact

  • The acquisition of restricted stock units by a director could positively influence shareholder sentiment.

Key Dates

DateDescription
05/02/2024Date of transaction: Peggie Pelosi acquired restricted stock units.
08/02/2024First vesting date: 25% of the restricted stock units vest.
11/02/2024Second vesting date: 25% of the restricted stock units vest.
02/02/2025Third vesting date: 25% of the restricted stock units vest.
05/02/2025Final vesting date: Remaining 25% of the restricted stock units vest.
05/03/2024Date of filing: Form 4 filed by Joshua Foukas, Attorney-in-Fact.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.